A New Era Of Scrutiny For China-Linked Pharma Deals
By Jen Maki · August 6, 2026, 5:43 PM EDT
Introduced in the U.S. House of Representatives on June 2, the Biotech Investment National Security Act represents a bipartisan attempt to expand U.S. outbound transaction controls....
To view the full article, register now.